Sophia Genetics signs over 850 hospitals to its “data-driven medicine”
22.01.2019
Share this article
Sophia Genetics closes it Series E funding round with a $77 million cash injection. The Swiss biotech is now used in over 850 hospitals, in 77 countries and supports the diagnosis of over 300’000 patients.